1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Chronic Disease Market Trends
  5. > Chronic Disease Analysis & Statistics 2021 - Northern Europe

Chronic Disease Analysis & Statistics 2021 - Northern Europe

Customer Support

Talk to Ahmad

+1 718 618 4302

Publishers

  • All
    • Delve Insight

All regions

  • All
    • Europe
      • Northern Europe
1-30 of 41 reports

Chronic Obstructive Pulmonary Disease (COPD) - Epidemiology forecast- 2030

  • $ 4750
  • August 2021
  • 180 pages

‘Chronic Obstructive Pulmonary Disease (COPD)—Epidemiology Forecast–2030’ report delivers an in-depth understanding of the Chronic Obstructive Pulmonary Disease (COPD), historical and forecasted ...

  • United States
  • Spain
  • Respiratory Disease
  • Industry analysis
  • Chronic Obstructive Pulmonary Disease Prevalence

Acute Ischemic Stroke - Pipeline Insight, 2021

  • $ 2000
  • May 2021
  • 60 pages

“Acute Ischemic Stroke – Pipeline Insight, 2021,” report provides comprehensive insights about 20+ companies and 20+ pipeline drugs in Acute Ischemic Stroke pipeline landscape. It covers the pipeline ...

  • United Kingdom
  • United States
  • Stroke
  • Industry analysis

Heart Failure - Epidemiology forecast- 2030

  • $ 3750
  • May 2021
  • 80 pages

‘Heart Failure (HF)—Epidemiology Forecast–2030’ report delivers an in-depth understanding of the HF, historical and forecasted epidemiology as well as the HF trends in the United States, EU5 (Germany, ...

  • United States
  • Spain
  • Heart Failure
  • Epidemiology
  • Industry analysis

Diabetic retinopathy - Epidemiology Forecast to 2030

  • $ 3750
  • April 2021
  • 90 pages

‘Diabetic Retinopathy (DR) – Epidemiology Forecast—2030’ report delivers an in-depth understanding of the Diabetic Retinopathy, historical and forecasted epidemiology in the United States, EU5 ...

  • United States
  • Germany
  • Type 2 Diabetes
  • Industry analysis
  • Diabetes Prevalence

BI 764524 - Emerging Insight and Market Forecast-2030

  • $ 3250
  • February 2021
  • 50 pages

“BI 764524 - Emerging Insight and Market Forecast – 2030” the report provides comprehensive insights about an investigational product for Diabetic Retinopathy in 7 Major Markets. A detailed picture ...

  • Europe
  • Japan
  • Type 2 Diabetes
  • Research And Development
  • Industry analysis
  • Health Expenditure

RG 7774 - Emerging Insight and Market Forecast - 2030

  • $ 3250
  • February 2021
  • 30 pages

“RG 7774 - Emerging Insight and Market Forecast - 2030” the report provides comprehensive insights about an investigational product for Diabetic Retinopathy in 7 Major Markets. A detailed picture of ...

  • Europe
  • Japan
  • Type 2 Diabetes
  • Research And Development
  • Industry analysis
  • Health Expenditure

Lucentis - Drug Insight and Market Forecast - 2030

  • $ 2750
  • February 2021
  • 30 pages

Overview “ Lucentis - Drug Insight and Market Forecast - 2030” report outlays comprehensive insights of the product indicated for the treatment of its approved condition. A detailed picture of the ...

  • Europe
  • World
  • Clinical Trial
  • Type 2 Diabetes
  • Industry analysis
  • Health Expenditure

BI 764524 - Emerging Insight and Market Forecast - 2030

  • $ 3250
  • February 2021
  • 30 pages

“BI 764524 - Emerging Insight and Market Forecast - 2030” the report provides comprehensive insights about an investigational product for Diabetic Retinopathy in 7 Major Markets. A detailed picture ...

  • Europe
  • Japan
  • Type 2 Diabetes
  • Research And Development
  • Industry analysis
  • Health Expenditure

CardiolRx-100 - Emerging Insights and Market Forecast - 2030

  • $ 3250
  • February 2021
  • 30 pages

“CardiolRx-100- Emerging Insight and Market Forecast – 2030” the report provides comprehensive insights about an investigational product for Myocarditis in 7 Major Markets. A detailed picture of ...

  • Europe
  • World
  • Research And Development
  • Clinical Trial
  • Industry analysis
  • Health Expenditure

Homozygous Familial Hypercholesterolemia - Epidemiology Forecast to 2030

  • $ 3750
  • January 2021
  • 80 pages

‘Homozygous familial hypercholesterolemia (HoFH) - Epidemiology Forecast – 2030’ report delivers an in-depth understanding of the disease, historical and forecasted Homozygous familial hypercholesterolemia ...

  • United States
  • Spain
  • Cardiovascular Disease
  • Industry analysis

Familial Hypercholesterolemia (Type II Hyperlipoproteinemia) - Epidemiology Forecast to 2030

  • $ 3750
  • January 2021
  • 80 pages

‘Familial Hypercholesterolemia (FH) - Epidemiology Forecast–2030’ report delivers an in-depth understanding of the disease, historical and forecasted Familial Hypercholesterolemia (FH) epidemiology ...

  • United States
  • France
  • Cardiovascular Disease
  • Industry analysis

Diabetic Foot Ulcer - Epidemiology Forecast – 2030

  • $ 3750
  • January 2021
  • 100 pages

‘Diabetic foot ulcer (DFU) - Epidemiology Forecast to 2030’ report delivers an in-depth understanding of the disease, historical and forecasted DFU epidemiology in the 7MM, i.e., the United States, ...

  • United States
  • Japan
  • Epidemiology
  • Type 2 Diabetes
  • Industry analysis
  • Smoking Prevalence
  • Mortality Rate

Diabetic Retinopathy (DR) – Epidemiology Forecast—2030

  • $ 3750
  • December 2020
  • 95 pages

‘Diabetic Retinopathy (DR) – Epidemiology Forecast—2030’ report delivers an in-depth understanding of the Diabetic Retinopathy, historical and forecasted epidemiology in the United States, EU5 ...

  • World
  • United States
  • Type 2 Diabetes
  • Industry analysis
  • Diabetes Prevalence

Adult-onset Still’s Disease – Epidemiology Forecast to 2030

  • $ 3750
  • December 2020
  • 65 pages

‘Adult-onset Still’s Disease – Epidemiology Forecast to 2030’ report delivers an in-depth understanding of the disease, historical, and forecasted Adult-onset Still’s Disease epidemiology in ...

  • United States
  • Japan
  • Musculoskeletal Disorder
  • Industry analysis

ISATUXIMAB- Emerging Insight and Market Forecast – 2030

  • $ 3250
  • December 2020
  • 60 pages

“ISATUXIMAB- Emerging Insight and Market Forecast – 2030” the report provides comprehensive insights about an investigational product for AL Amyloidosis in 7 Major Markets. A detailed picture of ...

  • Europe
  • Japan
  • Research And Development
  • Endocrine Disease
  • Industry analysis
  • Health Expenditure

CERC-007- Emerging Insight and Market Forecast – 2030

  • $ 3250
  • December 2020
  • 60 pages

“CERC-007- Emerging Insight and Market Forecast – 2030” the report provides comprehensive insights about an investigational product for Adult-onset Still’s Disease in 7 Major Markets. A detailed ...

  • Europe
  • Japan
  • Musculoskeletal Disorder
  • Research And Development
  • Industry analysis
  • Health Expenditure

ANAKINRA- Emerging Insight and Market Forecast – 2030

  • $ 3250
  • December 2020
  • 60 pages

“ANAKINRA- Emerging Insight and Market Forecast – 2030” the report provides comprehensive insights about an investigational product for Adult-onset Still’s Disease in 7 Major Markets. A detailed ...

  • Europe
  • Japan
  • Musculoskeletal Disorder
  • Research And Development
  • Industry analysis
  • Health Expenditure

Evobrutinib (M2951) - Emerging Drug Insight and Market Forecast – 2030

  • $ 3250
  • October 2020
  • 50 pages

“Evobrutinib (M2951) - Emerging Drug Insight and Market Forecast – 2030” the report provides comprehensive insights about an investigational product for Rheumatoid Arthritis in 7 Major Markets. A ...

  • Japan
  • Spain
  • Arthritis
  • Immunotherapy
  • Industry analysis
  • Health Expenditure

Otilimab (GSK3196165) - Emerging Drug Insight and Market Forecast – 2030

  • $ 2750
  • October 2020
  • 50 pages

“Otilimab (GSK3196165) - Emerging Drug Insight and Market Forecast – 2030” the report provides comprehensive insights about an investigational product for Rheumatoid Arthritis in 7 Major Markets. ...

  • Japan
  • Spain
  • Arthritis
  • Research And Development
  • Industry analysis
  • Health Expenditure

Olokizumab - Emerging Drug Insight and Market Forecast – 2030

  • $ 3250
  • October 2020
  • 50 pages

“Olokizumab - Emerging Drug Insight and Market Forecast – 2030” the report provides comprehensive insights about an investigational product for Rheumatoid Arthritis in 7 Major Markets. A detailed ...

  • Japan
  • Spain
  • Arthritis
  • Research And Development
  • Industry analysis
  • Health Expenditure

Filgotinib - Emerging Drug Insight and Market Forecast – 2030

  • $ 3250
  • October 2020
  • 50 pages

“Filgotinib - Emerging Drug Insight and Market Forecast – 2030” the report provides comprehensive insights about an investigational product for Rheumatoid Arthritis in 7 Major Markets. A detailed ...

  • Japan
  • Spain
  • Arthritis
  • Research And Development
  • Industry analysis
  • Health Expenditure

RT 100 - Emerging Drug Insight and Market Forecast – 2030

  • $ 3250
  • September 2020
  • 50 pages

“RT 100 - Emerging Drug Insight and Market Forecast – 2030” the report provides comprehensive insights about an investigational product for Heart failure in 7 Major Markets. A detailed picture of ...

  • Europe
  • Japan
  • Heart Failure
  • Gene Therapy
  • Industry analysis
  • Health Expenditure

PALOVAROTENE- Emerging Drug Insight and Market Forecast – 2030

  • $ 3250
  • September 2020
  • 50 pages

“PALOVAROTENE- Emerging Drug Insight and Market Forecast – 2030” the report provides comprehensive insights about an investigational product for Fibrodysplasia ossificans progressiva (FOP) in 7 Majo ...

  • Europe
  • Japan
  • Research And Development
  • Musculoskeletal Disorder
  • Industry analysis
  • Health Expenditure

Chronic kidney disease (CKD)- Epidemiology Forecast to 2030

  • $ 3750
  • May 2020
  • 100 pages

‘Chronic kidney disease (CKD)- Epidemiology Forecast to 2030’ report delivers an in-depth understanding of the disease, historical & forecasted epidemiology of Chronic kidney disease in the United ...

  • United States
  • Spain
  • Chronic Disease
  • Epidemiology
  • Industry analysis

Refractory Angina (RA)- Epidemiology Forecast to 2030

  • $ 3750
  • May 2020
  • 100 pages

‘Refractory Angina (RA) - Epidemiology Forecast to 2030’ report delivers an in-depth understanding of the disease, historical and forecasted Refractory Angina epidemiology in the 7MM, i.e., the United ...

  • United States
  • Spain
  • Angina
  • Industry analysis
  • Surgical Procedures Performed

Non-cystic Fibrosis Bronchiectasis (NCFB)- Epidemiology Forecast to 2030

  • $ 3750
  • May 2020
  • 100 pages

‘Non-cystic fibrosis bronchiectasis (NCFB) - Epidemiology Forecast to 2030’ report delivers an in-depth understanding of the disease, historical and forecasted Non-cystic fibrosis bronchiectasis epidemiology ...

  • Spain
  • France
  • Cystic Fibrosis
  • Respiratory Disease
  • Industry analysis

Pulmonary Arterial Hypertension - Epidemiology Forecast to 2030

  • $ 3750
  • April 2020
  • 98 pages

‘Pulmonary Arterial Hypertension - Epidemiology Forecast to 2030’ report delivers an in-depth understanding of the disease, historical & forecasted epidemiology of Pulmonary Arterial Hypertension in ...

  • Spain
  • France
  • Hypertension
  • Epidemiology
  • Industry analysis

Familial Hypercholesterolemia - Epidemiology Forecast to 2030

  • $ 3750
  • April 2020
  • 100 pages

‘Familial Hypercholesterolemia (FH) - Epidemiology Forecast–2030’ report delivers an in-depth understanding of the disease, historical and forecasted Familial Hypercholesterolemia (FH) epidemiology ...

  • France
  • Japan
  • Cardiovascular Disease
  • Industry analysis

Diabetic Gastroparesis (DGp)- Epidemiology Forecast-2030

  • $ 3750
  • March 2020
  • 90 pages

‘Diabetic Gastroparesis (DGp)- Epidemiology Forecast-2030’ report delivers an in-depth understanding of the disease, historical & forecasted epidemiology of DGp in the in 7MM covering the United States, ...

  • Spain
  • France
  • Diabetes
  • Industry analysis

Diabetic Retinopathy Market Insight, Epidemiology and Market Forecast -2030

  • $ 6950
  • April 2021
  • 191 pages

‘Diabetic Retinopathy (DR) – Market Insights, Epidemiology, and Market Forecast—2030’ report delivers an in-depth understanding of the Diabetic Retinopathy (DR), historical and forecasted epidemiology ...

  • United States
  • Japan
  • Type 2 Diabetes
  • Industry analysis
  • Diabetes Prevalence

Reportlinker.com © Copyright 2021. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on